Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • From Merchants to Builders: Dawoodi Bohra Expo Opens in Mumbai Amidst the City’s Infrastructure Boom Business
  • LYC2024 Announces the Launch of LycanChain and its Robust Ecosystem targeting Mass Adoption Business
  • Dr. Vijay Kishore Bansal Earns Recognition Through his Philanthropic Work Business
  • Influence Redefined: Confluencr’s Data-Driven Strategies for Success Technology
  • Regenerative Medicine: Innovation and Innovators leading online scientific event by IASRM in this pandemic Press Release
  • Vash Level 2: A Haunting Sequel That Dares More—but at What Cost? Entertainment
  • Yamraj Calling is back! Season 2 of India’s favourite family series is now screening on ShemarooMe Entertainment
  • Singer Yashita Sharma Hits The Right Note For The Wedding Season With Her New Single “Bidaai” Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Nissan expands network in Gujarat Business
  • Cressanda Solutions receives work order from Eastern Railways to provide advertisement and Concierge Services in over 500 trains Business
  • BNI Baroda to host BNI Colosseum on July 23-24 Business
  • A one of its kind Talent Hunt: Twinkle Twinkle Business
  • Patel Retail Limited Receives Export Authorization for Wheat Flour and Related Products from DGFT Business
  • Inter Dairy Expo 2024 to Showcase Innovations in India’s Dairy Industry from December 5 to 7 in Mumbai Business

Recent Posts

  • Women’s Contribution in 100 Years of RSS Highlighted at Mumbai Seminar on ‘Shatayu Sangh Aur Mahila Sahabhagita’
  • Ms Sreeleela joining hands with Chennais Amirta
  • Teaser of Krishna Aur Chitthi strikes an emotional chord, leaves audiences deeply moved
  • Mumbai Witnessed a Grand Premiere of Nitishali Production’s “Vaanki Chuki: Love Story” Amidst Glamour and Celebration
  • Subhash Choudhary : The ‘Accidental CTO’ whose journey from Bihar has been an engineering bestseller, has a net worth of Rs. 203 Crore.

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Speedforce is All Set to Take Over India With its exceptional Automobile Services Business
  • Serendipity Arts Launches THE BRIJ Cultural Leaders Fellowship, a nine-month Leadership Programme for Cultural Practitioners Business
  • Taking Healthcare to the Doorsteps of Villages: Truhome Finance, Utthaan, and DocOnline Launch Mobile Screening Camps Across Rajasthan Press Release
  • Flicka Cosmetics ropes in 2000 influencers to launch Flawless Femme Foundation Business
  • Navigating the Current Wave of New Fund Offers India Finance
  • Identityy by Treefe Onboards 100+ Digital Marketing Agencies, Strengthens India’s Social Media & Startup Ecosystem Technology
  • Silent sufferers: It’s time to talk about Pelvic Pain English
  • Apple Green Diamond’s Sustainable Gemstones to Adorn Ram Lalla Crown in Ayodhya National

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme